114 related articles for article (PubMed ID: 31704844)
21. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
[TBL] [Abstract][Full Text] [Related]
23. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of AIOLOS induces apoptosis and enhances etoposide chemosensitivity in Jurkat leukemia cells.
Zhuang Y; Lu Y; Li D; Sun N; Ju X
Oncol Rep; 2015 Mar; 33(3):1319-25. PubMed ID: 25524659
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.
Mann AP; Verma A; Sethi G; Manavathi B; Wang H; Fok JY; Kunnumakkara AB; Kumar R; Aggarwal BB; Mehta K
Cancer Res; 2006 Sep; 66(17):8788-95. PubMed ID: 16951195
[TBL] [Abstract][Full Text] [Related]
26. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
27. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
28. Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia.
Goossens S; Van Vlierberghe P
PLoS Med; 2016 Dec; 13(12):e1002208. PubMed ID: 27997538
[TBL] [Abstract][Full Text] [Related]
29. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
30. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
[TBL] [Abstract][Full Text] [Related]
31. TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy.
Zhang H; Chen Z; Miranda RN; Medeiros LJ; McCarty N
Cancer Res; 2016 Nov; 76(21):6410-6423. PubMed ID: 27488529
[TBL] [Abstract][Full Text] [Related]
32. Tissue transglutaminase (TG2) in cancer biology.
Mangala LS; Mehta K
Prog Exp Tumor Res; 2005; 38():125-38. PubMed ID: 15746533
[No Abstract] [Full Text] [Related]
33. The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone.
Xiang J; Wang G; Xia T; Chen Z
Biomed Pharmacother; 2019 Jan; 109():2210-2217. PubMed ID: 30551478
[TBL] [Abstract][Full Text] [Related]
34. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
Ayinde O; Wang Z; Griffin M
Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells.
Shrestha R; Tatsukawa H; Shrestha R; Ishibashi N; Matsuura T; Kagechika H; Kose S; Hitomi K; Imamoto N; Kojima S
Cell Death Dis; 2015 Dec; 6(12):e2002. PubMed ID: 26633708
[TBL] [Abstract][Full Text] [Related]
36. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
Lei J; Li Q; Gao Y; Zhao L; Liu Y
Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
[TBL] [Abstract][Full Text] [Related]
37. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
38. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
39. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression.
Banerjee K; Das S; Sarkar A; Chatterjee M; Biswas J; Choudhuri SK
Biomed Pharmacother; 2016 Dec; 84():71-92. PubMed ID: 27639544
[TBL] [Abstract][Full Text] [Related]
40. Treatment of human T-cell acute lymphoblastic leukemia cells with CFTR inhibitor CFTRinh-172.
Liu M; Liao H; Chen Y; Lin Z; Liu Y; Zhang X; Chan HC; Sun H
Leuk Res; 2019 Nov; 86():106225. PubMed ID: 31541940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
